Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR-NK”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06307054
What this trial is testing

CLL-1 CAR-NK Cells for Relapsed/Refractory AML

Who this might be right for
Relapsed Adult AMLRefractory AML
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 24
Early research (Phase 1)Looking for participantsNCT07382817
What this trial is testing

Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms

Who this might be right for
Neoplasms
M.D. Anderson Cancer Center 33
Very early researchUnknownNCT03824964
What this trial is testing

Study of Anti-CD19/CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Who this might be right for
Refractory B-Cell Lymphoma
Allife Medical Science and Technology Co., Ltd. 10
Early research (Phase 1)Not Yet RecruitingNCT05995028
What this trial is testing

Universal 4SCAR7U Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Very early researchUnknownNCT05673447
What this trial is testing

The Study of Anti-CD19 CAR NK Cells in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Changhai Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT06967038
What this trial is testing

Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome

Who this might be right for
Primary Sjogren's SyndromeLymphoma
Bangdong Gong 6
Testing effectiveness (Phase 2)Looking for participantsNCT07641036
What this trial is testing

Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer

Who this might be right for
CholangiocarcinomaIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+2 more
Beijing Biotech 30
Testing effectiveness (Phase 2)Looking for participantsNCT07500220
What this trial is testing

Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)Metastatic Liver Cancer
Beijing Biotech 30
Very early researchLooking for participantsNCT07490041
What this trial is testing

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases

Who this might be right for
Rheumatic DiseasesPediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)Systemic Lupus Erythematosus (SLE)+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Early research (Phase 1)Looking for participantsNCT06816823
What this trial is testing

CAR-NK Cells (CL-NK-001) in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Changhai Hospital 30
Early research (Phase 1)Looking for participantsNCT06464679
What this trial is testing

An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Changhai Hospital 72
Early research (Phase 1)Study completedNCT03049449
What this trial is testing

T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

Who this might be right for
Lymphoma, Large-Cell, AnaplasticEnteropathy-Associated T-Cell LymphomaLymphoma, Large B-Cell, Diffuse+2 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06856278
What this trial is testing

Clinical Study of NKG2D CAR-NK Combined with PD-1 Monoclonal Antibody in the Treatment of ATC

Who this might be right for
Anaplastic Throid Carcinoma
Zhejiang Provincial People's Hospital 30
Very early researchUnknownNCT05248048
What this trial is testing

NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer

Who this might be right for
Refractory Metastatic Colorectal Cancer
The Third Affiliated Hospital of Guangzhou Medical University 9
Early research (Phase 1)UnknownNCT05213195
What this trial is testing

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Refractory Metastatic Colorectal Cancer
Zhejiang University 38
Early research (Phase 1)Study completedNCT06464965
What this trial is testing

Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer

Who this might be right for
Gastric CancerPancreas Adenocarcinoma
Zhejiang Provincial People's Hospital 9
Early research (Phase 1)UnknownNCT05008575
What this trial is testing

Anti-CD33 CAR NK Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
Xinqiao Hospital of Chongqing 27
Very early researchLooking for participantsNCT06337474
What this trial is testing

An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia

Who this might be right for
Thrombocytopenia Alloimmune
Changzhou No.2 People's Hospital 9
Early research (Phase 1)Looking for participantsNCT06909474
What this trial is testing

Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies

Who this might be right for
T-ALL/Lymphoma
Chongqing Precision Biotech Co., Ltd 15
Very early researchLooking for participantsNCT06652243
What this trial is testing

Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 12
Next Page